Intranasal Therapy for Eligible Individuals
Explore how our Intranasal Therapy Program supports eligible individuals through a structured, clinician-supervised process. Learn about the treatment pathway, screening requirements, and ongoing clinical care provided across our NSW and QLD clinics.
What is Intranasal Therapy?
New Therapy via ARTG-Registered* Nasal Spray for Eligible Patients
Intranasal Therapy is a professionally administered option available to eligible individuals who have not found relief with conventional treatments. This Program involves the use of an ARTG-registered* nasal spray, provided under medical supervision in a structured clinical setting.
The process begins with an online screening form, followed by a telehealth appointment with a nurse practitioner and a comprehensive psychiatric assessment. If deemed appropriate, a personalised care plan is developed in consultation with our clinical team.
This Program is currently offered at our clinics in Sydney CBD and Samford Valley near Brisbane. Additional locations are planned for the NSW Central Coast and Townsville in 2025.
*ARTG ID 311827
What does the therapy process involve?
The Program follows a structured approach that is personalised to your clinical needs and response. Once approved, your care team will guide you through two key phases:
Induction Phase
Two sessions per week over four weeks, focused on establishing your baseline and monitoring clinical response.
Each session includes clinician supervision, risk oversight, and administrative support to ensure continuity of care.
Maintenance Phase
A gradual reduction to one session every fortnight, tailored to your progress and ongoing clinical review.
Each session is clinician-supervised and includes monitoring, support, and regular check-ins to ensure continuity of care.
We are committed to providing exceptional care and support to every patient, tailoring our services to meet your unique needs and circumstances.
Program Structure & Fees
The cost of participating in an Intranasal Therapy Program at GoodMind Therapeutics varies depending on individual circumstances and eligibility.
DVA Patients
Eligible veterans may be able to access this therapy with no out-of-pocket cost, subject to DVA approval on a case-by-case basis.
Private Patients
Som elements of this therapy is now subsidised under the PBS scheme (if deemed eligible).
Please contact us to obtain our Fees and Payment Guide.
Frequently asked questions about Intranasal Therapy
Intranasal Therapy is a professionally administered Program that uses an ARTG-registered* nasal spray. It is designed for eligible individuals who have not experienced sufficient relief with conventional treatments and is delivered under medical oversight in a structured clinical environment.
The nasal spray is administered via the nasal passages, allowing for rapid absorption through the mucous membranes. This supports fast-acting effects compared to traditional oral medications and is conducted in a supervised clinical setting.
This Program is typically considered for eligible individuals with treatment-resistant low mood or other persistent symptoms that have not responded to standard treatment options. Eligibility is determined on a case-by-case basis following a comprehensive assessment.
Intranasal Therapy is currently available at our Sydney CBD and Samford Valley (near Brisbane) clinics. Additional locations—including the NSW Central Coast and Townsville—are scheduled to open in 2025.
Eligible individuals self-administer the nasal spray during each session under direct clinical supervision. Sessions include ongoing observation to monitor response and ensure appropriate support.
Induction Phase (First 4 weeks): Two sessions per week to establish treatment response and baseline care.
Maintenance Phase: Gradual shift to one session every fortnight, adjusted based on individual progress and clinical recommendations.
Each session includes nasal spray administration followed by a monitoring period where clinical staff provide observation and check-ins. Adjustments to your care plan may be made based on your response.
Common side effects may include dizziness, nausea, or increased blood pressure. Your clinical team will discuss potential side effects with you in detail during your assessment and prior to your first session.
You’ll receive ongoing support throughout the Program, including regular check-ins, monitoring, and care planning from a multidisciplinary team.
A referral and screening process is required. Our clinicians will assess your medical history and current condition to determine if this approach is appropriate for your circumstances.
Register your interest
Interested in our innovative therapies for treatment resistant low mood and other mental health concerns?
If we currently don’t offer services in a location near you, we may do soon! Please fill out the form below and let us know where you live and what therapies interest you and we will let you know when we open up screenings in your area.